Psychedelicsubstances have been demonstrated to interact with a variety ofneurotransmitter pathways, including those involving serotonin, acetylcholine,norepinephrine, and dopamine. Currently, several stakeholders in thepharmaceutical industry are actively engaged in the efforts to develop leadsbased on natural and synthetic derivatives of psychedelic substances. Further,experts believe that psychedelics, at appropriate doses, can be used to addresssome of the serious psychological implications associated with the COVID-19pandemic.
Toorder this 250+ page report, which features 120+ figures and 135+ tables,please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
The over USD 6.5 billion (by2030) financial opportunity within the psychedelic therapeutics market has beenanalyzed across the following segments:
§ TargetDisease Indication
- Anxiety and Depression
- Trauma
- Pain Disorder
- Sleep related Disorder
§ Origin of Psychedelic Substance
- Natural
- Synthetic
§ Type of Psychedelic Substance
- Gamma-hydroxybutyrate
- Ketamine
- MDMA
- Psilocybin
§ Route of Administration
- Oral
- Intranasal
- Sublingual
§ Key Geographies
- North America
- Europe
- Asia-Pacific
The Global Psychedelic TherapeuticsMarket, 2020-2030 reportfeatures the following companies, which we identified to be key players in thisdomain:
§ Celon Pharma
§ iX Biopharma
§ MAPS Public Benefit
§ MindMed
§ Janssen Pharmaceuticals
§ Jazz Pharmaceutical
Torequest for sample - https://www.rootsanalysis.com/reports/318/request-sample.html
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape: Psychedelic Therapeutics
5. Company Profiles
6. Clinical Trial Analysis
7. Clinical Trial Site Analysis
9. Key Opinion Leader (KOL) Analysis
8. Academic Grants Analysis
10. Partnerships and Collaborations
11. Mergers and Acquisitions
12. Market Forecast and OpportunityAnalysis
13. Concluding Remarks
14. Executive Insights
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies andOrganizations
Topurchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
You may also beinterested in the following titles:
1. In Silico / Computer-Aided DrugDiscovery ServicesMarket: Focus on Large Molecules, 2020-2030
2. AR / VR basedHealthcare Digital Marketing Service Providers Market, 2020-2030
3. BioavailabilityEnhancement Technologies and Services Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
